316 related articles for article (PubMed ID: 24265711)
1. Differences in survival between colon and rectal cancer from SEER data.
Lee YC; Lee YL; Chuang JP; Lee JC
PLoS One; 2013; 8(11):e78709. PubMed ID: 24265711
[TBL] [Abstract][Full Text] [Related]
2. Tumor location as a novel high risk parameter for stage II colorectal cancers.
Wang B; Yang J; Li S; Lv M; Chen Z; Li E; Yi M; Yang J
PLoS One; 2017; 12(6):e0179910. PubMed ID: 28644878
[TBL] [Abstract][Full Text] [Related]
3. The survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: An analysis of 12,036 patients in the SEER database.
Huang B; Mo S; Zhu L; Xu T; Cai G
Oncotarget; 2016 Nov; 7(48):79787-79796. PubMed ID: 27806332
[TBL] [Abstract][Full Text] [Related]
4. Revised TN categorization for colon cancer based on national survival outcomes data.
Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart AK
J Clin Oncol; 2010 Jan; 28(2):264-71. PubMed ID: 19949014
[TBL] [Abstract][Full Text] [Related]
5. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
[TBL] [Abstract][Full Text] [Related]
6. Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients.
Abdel-Rahman O
Expert Rev Anticancer Ther; 2018 Feb; 18(2):187-192. PubMed ID: 29168934
[TBL] [Abstract][Full Text] [Related]
7. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010.
Bailey CE; Hu CY; You YN; Bednarski BK; Rodriguez-Bigas MA; Skibber JM; Cantor SB; Chang GJ
JAMA Surg; 2015 Jan; 150(1):17-22. PubMed ID: 25372703
[TBL] [Abstract][Full Text] [Related]
8. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system.
Chen VW; Hsieh MC; Charlton ME; Ruiz BA; Karlitz J; Altekruse SF; Ries LA; Jessup JM
Cancer; 2014 Dec; 120 Suppl 23(0 0):3793-806. PubMed ID: 25412391
[TBL] [Abstract][Full Text] [Related]
9. Primary Colorectal Lymphoma: Institutional Experience and Review of a National Database.
Hangge PT; Calderon E; Habermann EB; Glasgow AE; Mishra N
Dis Colon Rectum; 2019 Oct; 62(10):1167-1176. PubMed ID: 30489325
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous survival between stage IIA and stage IIIA colon cancer when different numbers of lymph nodes are harvested.
Huang B; Feng Y; Ni M; Chen C; Cai G
ANZ J Surg; 2018 Apr; 88(4):316-321. PubMed ID: 27580642
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio: role in the staging of node-positive colon cancer.
Wang J; Hassett JM; Dayton MT; Kulaylat MN
Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor size on overall survival and cancer-specific survival of early-onset colon and rectal cancer: a retrospective cohort study.
Yin W; Zhang M; Ji Z; Li X; Zhang S; Liu G
Int J Colorectal Dis; 2024 May; 39(1):69. PubMed ID: 38717476
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome.
Purim O; Gordon N; Brenner B
Med Sci Monit; 2013 Mar; 19():203-9. PubMed ID: 23511310
[TBL] [Abstract][Full Text] [Related]
15. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
16. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States.
Montminy EM; Zhou M; Maniscalco L; Abualkhair W; Kim MK; Siegel RL; Wu XC; Itzkowitz SH; Karlitz JJ
Ann Intern Med; 2021 Feb; 174(2):157-166. PubMed ID: 33315473
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
O'Connell JB; Maggard MA; Ko CY
J Natl Cancer Inst; 2004 Oct; 96(19):1420-5. PubMed ID: 15467030
[TBL] [Abstract][Full Text] [Related]
18. Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.
Lee JH; Yu M; Kim SH; Lee JH; Sung SY; Jeong BK; Jeong S; Nam TK; Jeong JU; Jang HS
Clin Colorectal Cancer; 2019 Mar; 18(1):e130-e139. PubMed ID: 30595556
[TBL] [Abstract][Full Text] [Related]
19. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum.
Tang R; Wang JY; Chen JS; Chang-Chien CR; Tang S; Lin SE; You YT; Hsu KC; Ho YS; Fan HA
J Am Coll Surg; 1995 Jun; 180(6):705-12. PubMed ID: 7773484
[TBL] [Abstract][Full Text] [Related]
20. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.
Garcia B; Guzman C; Johnson C; Hellenthal NJ; Monie D; Monzon JR
Surg Oncol; 2016 Sep; 25(3):158-63. PubMed ID: 27566017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
